Friday, April 15, 2011

Gardasil, the HPV vaccine and Cervical Cancer


We have a pretty broad idea right now about what we want to do. We are focusing on the recently released HPV vaccine, Gardasil which claims to help prevent the incidence of cervical cancer in women. This vaccine was approved in 2006 and was largely commercialized and pushed onto many patients. However, long term effects of the vaccine are not yet known. We want to explore both how the vaccine works on a molecular level and discover what the long term effects of the vaccine are. We are hoping to look into FDA and pharmaceutical documents preceding the approval of this drug to find what, if any adverse effects, the vaccine may have long-term. Clinical trials will also be used to examine the safety of the vaccine. Also, we are planning to explain how the vaccine should be used and its effectiveness in preventing HPV infection and resulting prevention of cervical cancer.